Legend Biotech (LEGN) Other Non Operating Income (2020 - 2025)
Legend Biotech's (LEGN) quarterly Other Non Operating Income came in at -$2.4 million in Q4 2025, down 102.15% YoY from $111.4 million in Q4 2024, and down 777.97% on a QoQ basis from $354000.0 in Q3 2025.
Legend Biotech (LEGN) Other Non Operating Income (2020 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 6 years of Other Non Operating Income data on file, last reported at -$2.4 million in Q4 2025.
- Quarterly Other Non Operating Income fell 102.15% year-over-year to -$2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$55.0 million (down 149.15% YoY) and the FY2025 annual result came in at -$164.8 million, down 247.41% from the prior year.
- Other Non Operating Income fell to -$2.4 million in Q4 2025, from $354000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $111.4 million in Q4 2024 to a low of -$108.1 million in Q2 2025.
- A 5-year average of $3.6 million and a median of $7.2 million in 2021 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 47372.73% in 2021, down 3437.55% in 2021.
- Tracing LEGN's Other Non Operating Income over 5 years: stood at $31.2 million in 2021, then plunged by 129.81% to -$9.3 million in 2022, then soared by 208.07% to $10.1 million in 2023, then soared by 1008.43% to $111.4 million in 2024, then slumped by 102.15% to -$2.4 million in 2025.
- The last three Other Non Operating Income figures came in at -$2.4 million (Q4 2025), $354000.0 (Q3 2025), and -$108.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.40 Mn |
| Sep 30, 2025 | 354,000.00 |
| Jun 30, 2025 | -108.13 Mn |
| Mar 31, 2025 | 55.19 Mn |
| Dec 31, 2024 | 111.40 Mn |
| Sep 30, 2024 | -61.66 Mn |
| Jun 30, 2024 | 12.44 Mn |
| Mar 31, 2024 | 49.68 Mn |
| Dec 31, 2023 | 10.05 Mn |
| Sep 30, 2023 | 75.61 Mn |
| Jun 30, 2023 | -105.75 Mn |
| Mar 31, 2023 | 20.00 Mn |
| Dec 31, 2022 | -9.30 Mn |
| Sep 30, 2022 | 61.20 Mn |
| Jun 30, 2022 | -65.90 Mn |
| Mar 31, 2022 | 34.90 Mn |
| Dec 31, 2021 | 31.20 Mn |
| Sep 30, 2021 | -35.80 Mn |
| Jun 30, 2021 | -5.95 Mn |
| Mar 31, 2021 | 4.35 Mn |